Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology-Reference-Cited by-同舟云学术

Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology

Published:2019 Issue: Volume: Page:327-367
ISSN:0171-2004
Container-title:Concepts and Principles of Pharmacology
language:
Short-container-title:

Author:

Taylor D. Lansing,Gough Albert,Schurdak Mark E.,Vernetti Lawrence,Chennubhotla Chakra S.,Lefever Daniel,Pei Fen,Faeder James R.,Lezon Timothy R.,Stern Andrew M.,Bahar Ivet

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/164_2019_239

Reference229 articles.

1. Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Phys 153:586–600. https://doi.org/10.1152/ajplegacy.1948.153.3.586

2. Alex A, Harris CJ, Keighley WW, Smith DA (2015) Compound Attrition in Phase II/III. In: Attrition in the pharmaceutical industry. https://doi.org/10.1002/9781118819586.ch4

3. Al-Hadiya BM, Bakheit AH, Abd-Elgalil AA (2014) Imatinib mesylate. Profiles Drug Subst Excip Relat Methodol 39:265–297. https://doi.org/10.1016/b978-0-12-800173-8.00006-4

4. Allarakhia M (2013) Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases. Drug Des Devel Ther 7:753–766. https://doi.org/10.2147/dddt.S46289

5. Allen GD (1990) MODFIT: a pharmacokinetics computer program. Biopharm Drug Dispos 11:477–498

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy;Frontiers in Cell and Developmental Biology;2024-09-11

2. A Microphysiological Model to Mimic the Placental Remodeling during Early Stage of Pregnancy under Hypoxia-Induced Trophoblast Invasion;Biomimetics;2024-05-12

3. Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy;2024-04-26

4. Bridging systems biology and tissue engineering: Unleashing the full potential of complex 3D in vitro tissue models of disease;Biophysics Reviews;2024-04-10

5. Reproducibility and Robustness of a Liver Microphysiological System PhysioMimix LC12 under Varying Culture Conditions and Cell Type Combinations;Bioengineering;2023-10-14